{"id":"W3171413004","doi":"10.1200/jco.2021.39.15_suppl.7523","title":"Up to seven years of follow-up in the RESONATE-2 study of first-line ibrutinib treatment for patients with chronic lymphocytic leukemia.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Ibrutinib; Chlorambucil; Medicine; Hazard ratio; Chronic lymphocytic leukemia; IGHV@; Internal medicine; Oncology; Neutropenia; Progression-free survival; Confidence interval; Gastroenterology; Leukemia; Chemotherapy; Cyclophosphamide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046604,0.001169626,0.001952983,0.0003936701,0.0008667388,0.001150828,0.000701525,0.001788407,0.00334594],"category_scores_gemma":[0.001940237,0.0007620429,0.002112465,0.0005089651,0.0005603713,0.001115818,0.0008160018,0.002297375,0.000756661],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008466581,"about_ca_system_score_gemma":0.001103071,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00167315,"about_ca_topic_score_gemma":0.002885265,"domain_scores_codex":[0.998809,0.0006279587,0.00005851436,0.000191393,0.00009450364,0.0002186592],"domain_scores_gemma":[0.998269,0.0002380509,0.0003698496,0.0001523478,0.0001111481,0.0008595932],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.8534113,0.01006886,0.1023401,0.0004157602,0.004265862,0.0002819136,0.0002392259,0.0006319743,0.002834516,0.0001173259,0.003514642,0.02187855],"study_design_scores_gemma":[0.3937645,0.1996082,0.3907282,0.0001847696,0.004895998,0.0005656908,0.0001618813,0.001266083,0.0008777698,0.0002985003,0.007560759,0.00008775057],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9901733,0.003881403,0.0002249925,0.0004172132,0.0001480322,0.0007153666,0.002601664,0.00002492365,0.00181307],"genre_scores_gemma":[0.9883522,0.001018743,0.0002702459,0.00105649,0.0002574026,0.001055259,0.006065843,0.00001101627,0.001912835],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0046604,"threshold_uncertainty_score":0.02464682,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1174128857134083,"score_gpt":0.4522031796915162,"score_spread":0.334790293978108,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}